Related Experiment Video

Updated: Mar 22, 2026

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

5.6K

We Avoid Antibiotic Lock Solutions due to Fear of Antibiotic Resistance

Namrata Krishnan1

  • 1Section of Nephrology, Department of Internal Medicine, Veterans Affairs Medical Center, Yale School of Medicine, West Haven, Connecticut.

Seminars in Dialysis
|April 11, 2016
PubMed

Insights

Antibiotic lock solutions (ABLs) effectively treat hemodialysis catheter-related bacteremia (CRB) and may avoid catheter replacement. Recent literature review shows ABLs do not increase antibiotic resistance, contrary to previous concerns.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Pharmacology

Background:

  • Catheter-related bacteremia (CRB) is a frequent and serious complication in hemodialysis patients.
  • Current guidelines recommend systemic antibiotics and catheter replacement for CRB, but catheter replacement has limitations.
  • Antibiotic lock solutions (ABLs) are an alternative for CRB prevention and treatment, especially when catheter preservation is desired.

Purpose of the Study:

  • To evaluate the efficacy of antibiotic lock solutions (ABLs) in treating hemodialysis catheter-related bacteremia (CRB).
  • To assess the potential link between ABL use and the development of antibiotic resistance.
  • To review current literature regarding ABLs as an alternative to catheter replacement in CRB management.

Main Methods:

  • Systematic review of recent literature concerning antibiotic lock solutions (ABLs) for hemodialysis catheter-related bacteremia (CRB).
  • Analysis of studies investigating the impact of ABLs on antibiotic resistance.
  • Comparison of ABLs with traditional treatment methods, including catheter replacement.

Main Results:

  • Antibiotic lock solutions (ABLs) demonstrate high effectiveness in both preventing and treating hemodialysis catheter-related bacteremia (CRB).
  • The widespread use of ABLs has not been associated with an increase in antibiotic resistance, according to recent literature.
  • ABLs offer a viable alternative to catheter replacement, particularly for patients prioritizing catheter salvage.

Conclusions:

  • Antibiotic lock solutions (ABLs) are a highly effective and safe option for managing hemodialysis catheter-related bacteremia (CRB).
  • Concerns regarding increased antibiotic resistance with ABL use are not supported by current evidence.
  • ABLs represent a valuable therapeutic strategy, potentially reducing the need for catheter replacement in CRB cases.

More Related Videos

Antibiotic Dereplication Using the Antibiotic Resistance Platform10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

11.8K
Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.8K

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.9K
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
44
Antibiotic Selection00:57

Antibiotic Selection

Overview
62.0K
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
10
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.3K
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
14